x
Your search term

Growth in Biotech: Argenx’s E2E Supply Network Planning Optimization

The customer

Argenx is a global biotech company specializing in the development of innovative, antibody-based therapies for rare autoimmune diseases. With estimated 2024 revenues exceeding €2.2 billion and a strong growth trajectory, argenx has established a commercial presence in over 30 countries.

  • Challenges

    • Difficulties in aligning supply chain planning across different regions and CMO partners
    • Time-intensive & complex to run what-if scenarios for demand, supply or production disruptions
    • Lacking ability to run end-to-end optimization within supply network planning
    • No integration between long-term network planning & order management

  • Solution

    Anaplan Implementation

    • Network modelling and optimization across all manufacturing sites
    • Scenario capabilities to evaluate demand/supply shifts, delays, or market expansions
    • Automated order creation through bi-directional integration with the ERP
    • Exception management to flag supply gaps, overstock, or planning conflicts

  • Results

    • Full end-to-end visibility & control across the global external manufacturing network

    • Ability to run on-the-fly scenarios to simulate demand, supply, or market changes

    • Reduction of planning errors and elimination of manual processes

    • Faster planning cycle through optimized plan generation & automated order creation

    • Strong foundation to support future product launches and scale planning capabilities across  brands

     

     

Curious to hear the story first-hand?

Check our on-demand webinar session together with Anaplan “Growth in Biotech: argenx’s End-to-End Supply Network Planning Optimization”

Want to see Anaplan in action?

Get in touch